GEMINA LABS
Gemina Labs utilizes biochemistry and digital technology to offer novel biosensors that ease up the diagnosis of medical conditions.
GEMINA LABS
Industry:
Biotechnology Data Integration Health Care Health Diagnostics Sensor
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.geminalabs.com
Total Employee:
1+
Status:
Active
Contact:
+1 604-562-4546
Email Addresses:
[email protected]
Total Funding:
2 M CAD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Global Site Tag
Similar Organizations
Chondrex
Chondrex specializes in biochemistry and immunology collagen and collagen-related materials for use in arthritis and inflammation research.
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Current Employees Featured
Stock Details
Official Site Inspections
http://www.geminalabs.com
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Gemina Labs"
About - Gemina Labs
A Canada-UK based company with proprietary chemistry that can fundamentally change the rapid in vitro diagnostics sector, especially lateral flow technology.. The chemistry platform is in our …See details»
Gemina Labs - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +1 604-562-4546 Gemina Labs has created and patented a transformative bio-chemistry platform that powers next-generation …See details»
Investors - Gemina Labs
[email protected]. Products: [email protected]. R&D Services: [email protected]. Investors: [email protected]. Stay in touch. We send occasional product, company and technology updates. We won't bombard …See details»
Gemina Labs - LinkedIn
Gemina Labs | 243 followers on LinkedIn. Next-generation bio-sensing platform for detecting a wide range of pathogens that affect humans and animals. | We are Gemina Labs, a point-of …See details»
Gemina Laboratories Ltd. | The Canadian Securities Exchange (CSE)
Aug 10, 2021 geminalabs.com Gemina Labs is a biosensor and diagnostic company with a unique and transformative proprietary biochemistry that significantly improves the performance …See details»
Gemina Laboratories - Overview, News & Similar companies
Dec 7, 2022 www.geminalabs.com. Revenue <$5 Million. Stock Symbol GLAB. Industry Business Services General Business Services . Recent News & Media. Gemina Laboratories …See details»
Gemina Labs Company Profile 2024: Stock …
Gemina Labs General Information Description. Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) and human wellness monitoring market under the name Gemina Labs.See details»
Syniad Innovations
Vancouver, BC – March 21st, 2024 – Syniad Innovations Inc. (“Syniad”) is pleased to announce that Gemina Laboratories Ltd. (CSE: GLAB) (FRA:8I7), a developer of transformative …See details»
Contact | Gemina Labs
For everything else, email: [email protected]. ABOUT Gemina Labs. We're an expanding company with an amazing piece of chemistry, innovative products and best-in-class R&D capabilities. Together, we can transform the in vitro …See details»
Gemina Laboratories - Craft
Jul 31, 2024 See insights on Gemina Laboratories including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Syniad Innovations
Jul 10, 2024 ACCELERATING COMMERCIALISATION . Vancouver, BC – July 10, 2024 – Syniad Innovations Inc. (“Syniad”) is pleased to announce that Gemina Laboratories Ltd. …See details»
Gemina Labs Announces Research and Development Appointments
Aug 30, 2021 Our technology drives testing platforms that are fast, affordable and accurate, and easily self-administered. Our development pipeline includes platforms for the rapid testing of …See details»
Gemina Labs Announces Listing on the Canadian Securities …
Aug 10, 2021 VANCOUVER, BC / ACCESSWIRE / August 10, 2021 /Gemina Laboratories Ltd. (CSE:GLAB) (the "Company" or "Gemina") is pleased to announce that the common shares of …See details»
Gemina Labs Antibody Immobilization Chemistry Platform …
May 17, 2023 Our technology drives testing platforms that are fast, affordable and accurate, and easily self-administered. Our development pipeline includes platforms for the rapid testing of …See details»
Gemina Labs Nears Completion of Phase 2 Human Patient Testing …
Apr 28, 2022 VANCOUVER, BC / ACCESSWIRE / April 28, 2022 /Gemina Laboratories Ltd. (CSE:GLAB) (FRA:8I7) (the "Company" or "Gemina") is pleased to announce that human …See details»
Gemina Board Profiles | Gemina Labs
[email protected]. Products: [email protected]. R&D Services: [email protected]. Investors: [email protected]. Stay in touch. We send occasional product, company …See details»
Gemina Labs Announces Major Breakthrough in Environmentally …
Jul 25, 2023 Our technology drives testing platforms that are fast, affordable and accurate, and easily self-administered. Our development pipeline includes platforms for the rapid testing of …See details»
Gemina Labs
This licence is the culmination of a programme of research commenced between Gemina and the University of British Columbia in 2021. It lays the foundation for expanding Gemina’s …See details»
News (All) - Gemina Labs
[email protected]. Products: [email protected]. R&D Services: [email protected]. Investors: [email protected]. Stay in touch. We send occasional product, company …See details»